Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1966 2
1968 1
1970 1
1976 1
1977 1
1978 1
1986 1
1987 2
1989 1
1990 3
1991 2
1993 2
1994 4
1995 3
1996 4
1997 9
1998 2
1999 4
2000 9
2001 8
2002 10
2003 7
2004 19
2005 17
2006 23
2007 29
2008 39
2009 41
2010 39
2011 50
2012 50
2013 58
2014 79
2015 84
2016 74
2017 75
2018 95
2019 94
2020 108
2021 123
2022 131
2023 118
2024 125
2025 146
2026 97

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,600 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean balachandran r[Auth] (200 results)?
S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis.
Deng L, Costa F, Blake KJ, Choi S, Chandrabalan A, Yousuf MS, Shiers S, Dubreuil D, Vega-Mendoza D, Rolland C, Deraison C, Voisin T, Bagood MD, Wesemann L, Frey AM, Palumbo JS, Wainger BJ, Gallo RL, Leyva-Castillo JM, Vergnolle N, Price TJ, Ramachandran R, Horswill AR, Chiu IM. Deng L, et al. Among authors: ramachandran r. Cell. 2023 Nov 22;186(24):5375-5393.e25. doi: 10.1016/j.cell.2023.10.019. Cell. 2023. PMID: 37995657 Free PMC article.
Hypertriglyceridaemia: an update.
Wierzbicki AS, Kim EJ, Esan O, Ramachandran R. Wierzbicki AS, et al. Among authors: ramachandran r. J Clin Pathol. 2022 Dec;75(12):798-806. doi: 10.1136/jclinpath-2021-207719. Epub 2022 Jun 16. J Clin Pathol. 2022. PMID: 35710321 Review.
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. Among authors: ramachandran r. J Am Soc Nephrol. 2025 Apr 1;36(4):668-678. doi: 10.1681/ASN.0000000520. Epub 2024 Oct 16. J Am Soc Nephrol. 2025. PMID: 39431468 Free PMC article.
Pregnancy-associated acute kidney injury - consensus report of the 32nd Acute Disease Quality Initiative workgroup.
Nelson-Piercy C, Srisawat N, Kashani K, Lumlertgul N, Murugan R, Rhee H, Chakravarthi R, Surapaneni T, Acharya A, Ankawi G, Bramham K, Cerda J, Clark K, Claure-Del Granado R, Gowrishankar S, Luyckx V, Menon S, Poli-de-Figueiredo CE, Ramachandran R, Sahay M, Samavedam S, Shemies R, Shetty MS, Wiles K, Wium L, Wu VC, Yadla M, Ronco C, Mehta RL, Ostermann M. Nelson-Piercy C, et al. Among authors: ramachandran r. Nat Rev Nephrol. 2025 Sep;21(9):633-646. doi: 10.1038/s41581-025-00979-6. Epub 2025 Jul 18. Nat Rev Nephrol. 2025. PMID: 40681846
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, Al-Hosaini K, Bäck M, Baker JG, Barnes NM, Bathgate R, Beaulieu JM, Beck-Sickinger AG, Behrens M, Bernstein KE, Bettler B, Birdsall NJM, Blaho V, Boulay F, Bousquet C, Bräuner-Osborne H, Burnstock G, Caló G, Castaño JP, Catt KJ, Ceruti S, Chazot P, Chiang N, Chini B, Chun J, Cianciulli A, Civelli O, Clapp LH, Couture R, Cox HM, Csaba Z, Dahlgren C, Dent G, Douglas SD, Dournaud P, Eguchi S, Escher E, Filardo EJ, Fong T, Fumagalli M, Gainetdinov RR, Garelja ML, de Gasparo M, Gerard C, Gershengorn M, Gobeil F, Goodfriend TL, Goudet C, Grätz L, Gregory KJ, Gundlach AL, Hamann J, Hanson J, Hauger RL, Hay DL, Heinemann A, Herr D, Hollenberg MD, Holliday ND, Horiuchi M, Hoyer D, Hunyady L, Husain A, IJzerman AP, Inagami T, Jacobson KA, Jensen RT, Jockers R, Jonnalagadda D, Karnik S, Kaupmann K, Kemp J, Kennedy C, Kihara Y, Kitazawa T, Kozielewicz P, Kreienkamp HJ, Kukkonen JP, Langenhan T, Larhammar D, Leach K, Lecca D, Lee JD, Leeman SE, Leprince J, Li XX, Lolait SJ, Lupp A, Macrae R, Maguire J, Malfaci… See abstract for full author list ➔ Alexander SPH, et al. Among authors: ramachandran r. Br J Pharmacol. 2023 Oct;180 Suppl 2(Suppl 2):S23-S144. doi: 10.1111/bph.16177. Br J Pharmacol. 2023. PMID: 38123151 Free PMC article.
How Do We Pay for Glaucoma Screening?
Ramachandran R, Ehrlich JR, Stein JD. Ramachandran R, et al. J Glaucoma. 2024 Aug 1;33(Suppl 1):S67-S70. doi: 10.1097/IJG.0000000000002416. Epub 2024 Aug 19. J Glaucoma. 2024. PMID: 39149953 No abstract available.
Long term outcomes in drug resistant tuberculosis with Bedaquiline, Pretomanid and varying doses of Linezolid.
Daniel BD, Shanmugam S, Mehta R, Bhalla M, Mariappan M, Ramraj B, Awasthi AK, Patel P, Jain A, Jain P, Kumar C, Oswal V, Singla N, Kumar S, Dave J, Vadgama P, Bhatnagar AK, Kant S, Prabhakaran R, Tamakuwala G, Mukherjee RN, Santhanakrishnan RK, Ravikumar D, Nagarajan NK, Kumaravadivelu S, Bharathi J, Sridhar A, Ramachandran R, Matoo SK, Ponnuraja C, Jaju J, Padmapriyadarsini C. Daniel BD, et al. Among authors: ramachandran r. J Infect. 2025 Jul;91(1):106509. doi: 10.1016/j.jinf.2025.106509. Epub 2025 May 15. J Infect. 2025. PMID: 40381662 Free PMC article. Clinical Trial.
Ocular manifestations in IgA nephropathy.
Oo HH, Choy MYD, Arora A, Yeo SC, Ramachandran R, Gupta V, McCluskey P, Agrawal R. Oo HH, et al. Among authors: ramachandran r. Surv Ophthalmol. 2023 Mar-Apr;68(2):290-307. doi: 10.1016/j.survophthal.2022.09.004. Epub 2022 Oct 1. Surv Ophthalmol. 2023. PMID: 36191648 Review.
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.
Badve SV, Perkovic V, Jha V, Ramachandran R, Mushahar L, Menne J, De Vriese AS, Rossignol P, Flahault A, Al Ammari M, Skhiri H, Walsh M, Collister D, Liew A, Billot L, Bompoint S, Devaux A, Jun M, Lin E, Ramos da Cruz A, Ha JT, Eikelboom JW, Shaman A, Jardine MJ, Jesudason S, Wong MG, Anderson CS, Garg AX, Heerspink HJL, Monaghan H, Patel A, Mark PB, Wheeler DC, Lv J, Zuo L, Pilmore H, Gallagher M; TRACK Trial Investigators. Badve SV, et al. Among authors: ramachandran r. JAMA. 2026 Jun 4:e269379. doi: 10.1001/jama.2026.9379. Online ahead of print. JAMA. 2026. PMID: 42240165
1,600 results